Medicinal Chemistry in Eastern England--16th Symposium.
Norman
Peter
P
Norman Consulting, 18 Pink Lane, Burnham, Bucks SL1 8JW, UK. petrosn@bigfoot.com
D000818:Animals; D014150:Antipsychotic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D065169:Bradykinin B1 Receptor Antagonists; D065100:CCR5 Receptor Antagonists; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008660:Metabolism / Q000235:genetics; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D052247:Nitric Oxide Synthase Type II; D010600:Pharmacology / Q000639:trends*; D043783:Receptor, Bradykinin B1 / Q000737:chemistry; D018340:Receptors, Adrenergic, alpha-1 / Q000737:chemistry / Q000187:drug effects / Q000235:genetics; D054397:Receptors, CCR3; D019707:Receptors, Chemokine / Q000037:antagonists & inhibitors
D014150:Antipsychotic Agents; D065169:Bradykinin B1 Receptor Antagonists; C515350:CCR3 protein, human; D065100:CCR5 Receptor Antagonists; D004791:Enzyme Inhibitors; D043783:Receptor, Bradykinin B1; D018340:Receptors, Adrenergic, alpha-1; D054397:Receptors, CCR3; D019707:Receptors, Chemokine; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II